Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Min Huang

Showing results (361-370 of 378) with videos related to

Pageof 38
Sort By:
NPJ Vaccines|February 12, 2026
A randomised trial of a bioreactor-produced EV-A71 vaccine for endemic control in childrenKao-Pin Hwang, Quang Chan Luong, Yhu-Chering Huang, et al.
Influenza and Other Respiratory Viruses|July 28, 2023
Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trialLi-Min Huang, Andreas Schibler, Yi-Chuan Huang, et al.
The Journal of Infectious Diseases|June 8, 2017
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized TrialLi-Min Huang, Thanyawee Puthanakit, Chiu Cheng-Hsun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2025
Efficacy, immunogenicity, and safety of an investigational maternal respiratory syncytial virus prefusion F protein-based vaccinePeyman Banooni, Bernard Gonik, Cristina Epalza, et al.
The Journal of Infectious Diseases|July 13, 2013
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in childrenJoanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, et al.
Vaccine|July 20, 2002
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy childrenYu-Lung Lau, S J Rupert Vessey, Ivan S F Chan, et al.
Lancet (London, England)|April 15, 2022
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trialTrong Toan Nguyen, Cheng-Hsun Chiu, Chien-Yu Lin, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 3, 2025
Recommendation for immune prophylaxis of respiratory syncytial virus infection in childrenPing-Ing Lee, Yhu-Chering Huang, Chih-Jung Chen, et al.
Nature Genetics|March 27, 2012
Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysisYi-Ching Lee, Ho-Chang Kuo, Jeng-Sheng Chang, et al.
The Journal of Infectious Diseases|December 9, 2022
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of AgeJavier Díez-Domingo, Xavier Sáez-Llorens, Miguel A Rodriguez-Weber, et al.
Pageof 38

Showing results (361-370 of 378) with videos related to

Sort By:
Pageof 38
NPJ Vaccines|February 12, 2026
A randomised trial of a bioreactor-produced EV-A71 vaccine for endemic control in childrenKao-Pin Hwang, Quang Chan Luong, Yhu-Chering Huang, et al.
Influenza and Other Respiratory Viruses|July 28, 2023
Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trialLi-Min Huang, Andreas Schibler, Yi-Chuan Huang, et al.
The Journal of Infectious Diseases|June 8, 2017
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized TrialLi-Min Huang, Thanyawee Puthanakit, Chiu Cheng-Hsun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2025
Efficacy, immunogenicity, and safety of an investigational maternal respiratory syncytial virus prefusion F protein-based vaccinePeyman Banooni, Bernard Gonik, Cristina Epalza, et al.
The Journal of Infectious Diseases|July 13, 2013
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in childrenJoanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, et al.
Vaccine|July 20, 2002
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy childrenYu-Lung Lau, S J Rupert Vessey, Ivan S F Chan, et al.
Lancet (London, England)|April 15, 2022
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trialTrong Toan Nguyen, Cheng-Hsun Chiu, Chien-Yu Lin, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 3, 2025
Recommendation for immune prophylaxis of respiratory syncytial virus infection in childrenPing-Ing Lee, Yhu-Chering Huang, Chih-Jung Chen, et al.
Nature Genetics|March 27, 2012
Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysisYi-Ching Lee, Ho-Chang Kuo, Jeng-Sheng Chang, et al.
The Journal of Infectious Diseases|December 9, 2022
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of AgeJavier Díez-Domingo, Xavier Sáez-Llorens, Miguel A Rodriguez-Weber, et al.
Pageof 38